LAURA NISHI: Open Payments
NPI 1821040049 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 4 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $130 |
| Calliditas Therapeutics US Inc. | 1 | $118 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $75 |
Products named: TARPEYO, Kerendia, Vanrafia, Fabhalta.
Industry payments across IL — which companies pay providers there.
